<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE us-patent-application SYSTEM "us-patent-application-v43-2012-12-04.dtd" [ ]><us-patent-application lang="EN" dtd-version="v4.3 2012-12-04" file="US20140005138A1-20140102.XML" status="PRODUCTION" id="us-patent-application" country="US" date-produced="20131218" date-publ="20140102"><us-bibliographic-data-application lang="EN" country="US"><publication-reference><document-id><country>US</country><doc-number>20140005138</doc-number><kind>A1</kind><date>20140102</date></document-id></publication-reference><application-reference appl-type="utility"><document-id><country>US</country><doc-number>13981694</doc-number><date>20120120</date></document-id></application-reference><us-application-series-code>13</us-application-series-code><priority-claims><priority-claim sequence="01" kind="national"><country>CN</country><doc-number>201110028107.3</doc-number><date>20110126</date></priority-claim></priority-claims><classifications-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>C</section><class>07</class><subclass>H</subclass><main-group>19</main-group><subgroup>16</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr></classifications-ipcr><classifications-cpc><main-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>C</section><class>07</class><subclass>H</subclass><main-group>19</main-group><subgroup>16</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></main-cpc></classifications-cpc><classification-national><country>US</country><main-classification>514 46</main-classification><further-classification>536 2763</further-classification></classification-national><invention-title id="d0e61">Ribofuranosyl Purine Compounds, Methods for Preparing the Same and Use Thereof</invention-title><us-parties><us-applicants><us-applicant sequence="00" app-type="applicant" designation="us-only"><addressbook><last-name>Du</last-name><first-name>Hongguang</first-name><address><city>Beijing</city><country>CN</country></address></addressbook><residence><country>CN</country></residence></us-applicant><us-applicant sequence="01" app-type="applicant" designation="us-only"><addressbook><last-name>Liu</last-name><first-name>Guocheng</first-name><address><city>Beijing</city><country>CN</country></address></addressbook><residence><country>CN</country></residence></us-applicant><us-applicant sequence="02" app-type="applicant" designation="us-only"><addressbook><last-name>Ding</last-name><first-name>Zhongren</first-name><address><city>Shanghai</city><country>CN</country></address></addressbook><residence><country>CN</country></residence></us-applicant><us-applicant sequence="03" app-type="applicant" designation="us-only"><addressbook><last-name>Wang</last-name><first-name>Shuming</first-name><address><city>Beijing</city><country>CN</country></address></addressbook><residence><country>CN</country></residence></us-applicant></us-applicants><inventors><inventor sequence="00" designation="us-only"><addressbook><last-name>Du</last-name><first-name>Hongguang</first-name><address><city>Beijing</city><country>CN</country></address></addressbook></inventor><inventor sequence="01" designation="us-only"><addressbook><last-name>Liu</last-name><first-name>Guocheng</first-name><address><city>Beijing</city><country>CN</country></address></addressbook></inventor><inventor sequence="02" designation="us-only"><addressbook><last-name>Ding</last-name><first-name>Zhongren</first-name><address><city>Shanghai</city><country>CN</country></address></addressbook></inventor><inventor sequence="03" designation="us-only"><addressbook><last-name>Wang</last-name><first-name>Shuming</first-name><address><city>Beijing</city><country>CN</country></address></addressbook></inventor></inventors></us-parties><assignees><assignee><addressbook><orgname>BEIJING KBD PHARMACEUTICALS CO., LTD.</orgname><role>03</role><address><city>Road, Haidian District,  Beijing</city><country>CN</country></address></addressbook></assignee><assignee><addressbook><orgname>BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY</orgname><role>03</role><address><city>Beijing</city><country>CN</country></address></addressbook></assignee></assignees><pct-or-regional-filing-data><document-id><country>WO</country><doc-number>PCT/CN2012/000104</doc-number><kind>00</kind><date>20120120</date></document-id><us-371c124-date><date>20130917</date></us-371c124-date></pct-or-regional-filing-data></us-bibliographic-data-application><abstract id="abstract"><p id="p-0001" num="0000">The present invention relates to the compounds of the formulae (I) and (I-1) and the process for preparing the same, uses of the compounds for the treatment of diseases associated with platelet aggregation and in the manufacture of a medicament for the treatment of diseases associated with platelet aggregation, and relates to a pharmaceutical composition and a pharmaceutical formulation containing the compounds, wherein the definitions of R<sub>1</sub>, R<sub>2</sub>, R<sub>3 </sub>and R<sub>2a </sub>in the formulae are the same as those in the description.</p><p id="p-0002" num="0000"><chemistry id="CHEM-US-00001" num="00001"><img id="EMI-C00001" he="86.61mm" wi="68.66mm" file="US20140005138A1-20140102-C00001.TIF" alt="embedded image" img-content="chem" img-format="tif"/></chemistry></p></abstract></us-patent-application>